tiprankstipranks
Trending News
More News >
Grace Therapeutics, Inc. (GRCE)
NASDAQ:GRCE
US Market

Grace Therapeutics (GRCE) Cash flow

Compare
1,172 Followers

Grace Therapeutics Cash Flow

GRCE's free cash flow for Q2 2026 was C$-3.15M. For the 2026 fiscal year, GRCE's free cash flow was decreased by C$-2.55M and operating cash flow was C$-3.15M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
C$ -14.90MC$ -12.33MC$ -15.91MC$ -17.23MC$ -14.32M
Investing Cash Flow
C$ 0.00C$ 104.00KC$ 13.15MC$ -3.52MC$ -9.86M
Financing Cash Flow
C$ 14.03MC$ 7.36MC$ 304.00KC$ 0.00C$ 59.49M
End Cash Position
C$ 22.13MC$ 23.00MC$ 27.88MC$ 30.34MC$ 50.94M
Free Cash Flow
C$ -14.90MC$ -12.36MC$ -15.93MC$ -17.23MC$ -14.39M
Currency in CAD

Grace Therapeutics Cash Flow